MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Supine hypertension is longitudinally associated with cognitive decline in Parkinson disease independent of orthostatic hypotension

    C. Miller-Patterson, J. Hsu, M. Barrett, L. Cloud, T. Chelimsky (Richmond, USA)

    Objective: To determine whether orthostatic hypotension (OH) and/or supine hypertension (SH) are longitudinally associated with cognitive decline in Parkinson disease (PD). Background: Cognitive impairment is…
  • 2023 International Congress

    Assessing non-motor symptoms and associations with quality of life among patients in Korle-Bu Teaching Hospital, Ghana

    D. Brodie-Mends, F. Duodu, K. Nkromah, A. Akpalu (Accra, Ghana)

    Objective: To determine the prevalence and types of non-motor symptoms (NMS) and their relation to quality of life among Parkinson’s disease (PD) patients who attend…
  • 2023 International Congress

    Real-World Utilization of Istradefylline Among Patients with Parkinson’s Disease

    M. Rezak, J. Qian, Y. Zhao, A. Silverstein, J. Chamber, J. Swindle, N. Kronfeld, P. Lewitt (Hoffman estates, USA)

    Objective: This study examined real-world utilization of istradefylline and other PD-related medications before and after istradefylline initiation. Background: Istradefylline is indicated as adjunctive therapy to…
  • 2023 International Congress

    Levodopa-induced orthostatic hypotension in parkinsonism: a red flag of autonomic failure

    I. Cani, P. Guaraldi, G. Giannini, L. Sambati, G. Barletta, P. Cortelli, G. Calandra-Buonaura (Bologna, Italy)

    Objective: To evaluate the cardiovascular and hemodynamic effect of LD in patients with parkinsonism on chronic LD treatment. Background: Levodopa (LD) is the main treatment…
  • 2023 International Congress

    Globus pallidus interna deep brain stimulation for Parkinson’s Disease: Impact on Restless Legs Syndrome

    A. Wiltshire, A. Mahes, S. Wang, R. Zuzuárregui (San Francisco, USA)

    Objective: The goal of this study was to evaluate the impact of deep brain stimulation (DBS) of the globus pallidus interna (GPi) on Restless Legs…
  • 2023 International Congress

    Needs assessment of patients with Parkinson’s disease: a qualitative study

    N. Geraminejad, A. Darvishpoor Kakhki (Tehran, Islamic Republic of Iran)

    Objective: This research was conducted with a qualitative approach to assess the needs of patients with Parkinson's disease Background: In the health system, the provision…
  • 2023 International Congress

    A multicenter, matched case-control study of alpha-synuclein accumulation in the gastrointestinal tract of Parkinson’s disease

    C. Shin, S. Kim, SH. Park, JM. Kim, JY. Lee, SJ. Chung, JW. Kim, TB. Ahn, KW. Park, JH. Shin, CY. Lee, HJ. Lee, SH. Kong, YS. Suh, HK. Yang, HJ. Kim, B. Jeon (Sejong-si, Republic of Korea)

    Objective: 1) To determine the possibility as a pathologic biomarker of alpha-synuclein (AS) accumulation in the gastrointestinal (GI) tract in patients with Parkinson’s disease (PD) and…
  • 2023 International Congress

    monogenic parkinsonism in latin america: systematic review and meta-analysis

    P. Saffie-Awad, D. Texeira, P. Chana-Cuevas, A. Schumacher-Schuh (Santiago, Chile)

    Objective: This study aims to assess the frequency, distribution and the minimum prevalence of monogenic Parkinsonism in Latin America (LA) Background: The prevalence of monogenic…
  • 2023 International Congress

    An Open-Access Model for Parkinson’s Disease Progression

    S. Mosovsky, K. Saboo, K. Severson, A. Amini, L. Crawford, N. Yates, J. Adibi, L. Chahine (Pittsburgh, USA)

    Objective: To model the progression of PD by developing a hidden Markov model which incorporates nonlinear effects of disease severity and medication on clinical scores.…
  • 2023 International Congress

    A 20-year review of a Movement Disorders Database in Singapore

    YH. Nah, S. Neo, S. Ng, N. Chia, HL. Ng, W. Li, A. Zhan, KY. Tay, Z. Xu, WL. Au, L. Tan (Singapore, Singapore)

    Objective: To conduct a 20-year review of the movement disorders (MD) clinical database in Singapore. Background: MDs contribute to a significant portion of chronic disease…
  • « Previous Page
  • 1
  • …
  • 283
  • 284
  • 285
  • 286
  • 287
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley